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Emergence of invasive behavior in cancer is life-
threatening, yet ill-defined due to its multifacto-
rial nature. We present a multiscale mathemat-
ical model of cancer invasion, which considers
cellular and microenvironmental factors simul-
taneously and interactively. Unexpectedly, the
model simulations predict that harsh tumor
microenvironment conditions (e.g., hypoxia,
heterogenous extracellular matrix) exert a dra-
matic selective force on the tumor, which grows
as an invasive mass with fingering margins,
dominated by a few clones with aggressive
traits. In contrast, mild microenvironment con-
ditions (e.g., normoxia, homogeneous matrix)
allow clones with similar aggressive traits to
coexist with less aggressive phenotypes in a
heterogeneous tumor mass with smooth, non-
invasive margins. Thus, the genetic make-up
of a cancer cell may realize its invasive potential
through a clonal evolution process driven by
definable microenvironmental selective forces.
Ourmathematical model provides a theoretical/
experimental framework to quantitatively char-
acterize this selective pressure for invasion
and test ways to eliminate it.
INTRODUCTION
It is widely accepted that tumors evolve by clonal selection
of cell populations that proliferate in an unconstrained
manner, accumulatemutations, and compete for nutrients
or space (Nowell, 1976). In the current paradigm, as a re-
sult of mutation in critical genes, the cancer tissue be-
comes increasingly aggressive, locally invasive, and ulti-
mately metastatic (Fearon and Vogelstein, 1990). While it
is easy to envision the elements of selection for nutrientsor space in tumor growth (Hanahan and Weinberg,
2000), selective pressure for invasion and metastasis is
less obvious (Liotta and Kohn, 2003). The prevailing view
is that geno/phenotypes thatmeet all requirements forme-
tastasis are a rare occurrence in a primary tumor, in agree-
ment with the observed inefficiency of metastasis (Liotta
and Kohn, 2003). However, this view has been seriously
challenged by recent data showing that metastatic tumors
bear a molecular signature that also dominates in the orig-
inating primary tumor (Ramaswamy et al., 2003). Further-
more, there is little understanding of the paradox that cer-
tain cancers (e.g., small cell lung cancer) metastasize
early, while still small, whereas other tumors (e.g., breast
adenocarcinoma) metastasize as a function of size.
Thus, the mechanism of selection for invasive cancer cells
remains an open fundamental question in cancer biology.
It is generally agreed that cancer invasion is the out-
come of a complex, multifactorial interplay between can-
cer cells and the host tissue microenvironment since
explanations of invasion based on single factors appear
to be inadequate (Liotta and Kohn, 2001). Mathematical
modeling is an ideal approach for teasing apart mecha-
nisms of cancer invasion because it can simultaneously
and quantitatively consider interactions between multiple
factors (Araujo andMcElwain, 2004; Chaplain, 1996). Here
we report from amultiscale mathematical model of cancer
invasion results that show good predictive ability and intu-
itive links with cancer pathology and experimentation. In
our mathematical model, the behavior of cancer cells is
based on a set of equations for how individual cells
grow, divide, move (both random and directed motion),
mutate, and interact with each other (cell-cell adhesion,
crowding) and themicroenvironment (including consump-
tion of nutrients and production of enzymes) (for a com-
plete mathematical derivation, see Anderson, 2005).
From a mathematical point of view, some of these
variables are continuous (describing densities or concen-
trations rather than individual entities) and some discrete
(describing single entities). Therefore, our primary ap-
proach is based on a hybrid discrete-continuum (HDC)
model in which both discrete stochastic and continuumCell 127, 905–915, December 1, 2006 ª2006 Elsevier Inc. 905
Figure 1. Movement Probabilities for
Tumor Cells in the HDC Model
Intuitively, the model can be thought of as rep-
resenting a slice of tumor on amathematical lat-
tice. The four equationsP1-4 represent theprob-
ability of a single cell located at the lattice
coordinates (i,j) moving to a neighboring point
on the lattice. Each cell is assumed to have an
intrinsic unbiased motility [of rate DN] and
biased motility driven by haptotaxis (of rate c)
toward higher ECM concentrations (f). The
equation P0 represents the probability of a cell
being stationary. It takes into account the situa-
tion when a single cell does not experience a
gradient between neighboring points because
they contain equal concentrations of ECM; if
neighboring points contain higher (lower) ECM
concentrations, the probability of being station-
ary is diminished (increased) by the sign and
magnitude of the term ðf qi +1; j + f qi1; j  4f qi; j +
f qi; j + 1 + f
q
i; j1Þ: For a full mathematical derivation
of these equations, please see Anderson, 2005.deterministic variables are coupled (Anderson, 2005;
Anderson and Chaplain, 1998; Anderson et al., 1997,
2000). Because of its hybrid nature (cells treated as dis-
crete entities and microenvironmental parameters treated
as concentrations), the model can be directly linked to
experimental measurements of those cellular and micro-
environmental parameters recognized by cancer biolo-
gists as important in cancer invasion. Furthermore, the
fundamental unit of the model is the cell, and the complex
collective behavior of the tumor emerges as a conse-
quence of interactions between factors influencing the
life cycle and movement of individual cells.
RESULTS
Since we are interested in predicting invasion, our model
produces simulations of the growth of a vascularized solid
tumor (though, for simplicity, mathematical representation
of vascularization is kept to a minimum at this stage). To
describe cell motility in mathematical terms, cells are
located on a two-dimensional lattice (Figure 1) that repre-
sents the tissue domain in which cells live, including extra-
cellular matrix and other factors. Cells are allowed tomove
to free neighboring positions on the lattice according to
movement probabilities defined by the equations in Fig-906 Cell 127, 905–915, December 1, 2006 ª2006 Elsevier Inc.ure 1. The model calculates movement probabilities by
first considering cell-matrix interactions that may drive
motility. However, before any movement can occur, the
influence of other crucial cellular parameters such as
cell-cell adhesion and proliferation is also considered.
To include these parameters, each cell is given an indi-
vidual life cycle flow chart that takes into account both cell
phenotype and microenvironmental influences (Figure 2).
Its components include both basic metabolic processes,
such as proliferation and oxygen consumption rates, as
well as motility-related ones, such as the propensity to
undergo haptotaxis and engage in cell-cell adhesion. In
addition, interactions with the microenvironment are gov-
erned by three key continuous variables: extracellular ma-
trix (ECM) macromolecule concentration (denoted by f),
the concentration of the matrix-degrading enzyme (MDE)
(denoted by m) secreted by the cell to break down the
ECM, and oxygen concentration (denoted by c). Note
that oxygen could be representative of any nutrient or
nutrients in general necessary for tumor cell survival. The
ECM is the macromolecular environment surrounding
cells and so has distinct composition and structure
depending on the location of the tumor (e.g., lung, breast,
prostate, bone, etc.). The equations describing cell inter-
actions with ECM, MDEs, and oxygen are:
where Dm and Dc are the MDE and oxygen diffusion co-
efficients, respectively; m, l, d, a, g, and b are positive con-
stants. The Ni,j term in each of these represents a tumor
cell located at lattice position (i,j) and is either one if
a cell is present or zero if it is not. Oxygen is assumed to
diffuse, decay naturally, and be consumed by the tumor.
To minimize the modeling of tumor vascularization, oxy-
gen production is proportional to the ECMmacromolecule
(MM) density. However, it must be stressed that uncou-
pling oxygen production from ECM density produces
similar results in the simulations (data not shown). The
multiscale nature of the HDC model facilitates incorpora-
tion, at a later time, of a complex angiogenesis supply
model (Anderson andChaplain, 1998), more sophisticated
models for cell movement, more detailed modeling of in-
tracellular processes, or other variables.
The life-cycle flow chart is the core engine of the HDC
model and provides a natural link between mathematics
and biological experimentation (Figure 2). This is because
each cell behaves on its own, based on a phenotype de-
termined both by genetic make-up and microenvironmen-
tal interactions. The ability to assign a phenotype to each
individual cell is a fundamental property of our HDC
approach. The advantage of the HDC approach with phe-
notypes is perhaps best illustrated by its evolution from
a previous, purely continuous treatment (Anderson et al.,
2000) in which all variables, including cells, were treated
mathematically as continuous and solved as partial differ-
ential equations (changing in both space and time). In this
earlier version (Figure 3, upper panels), simulation of
tumor cells growing in a ‘‘bumpy’’ ECM (see below and
legends to Figures 3 and 4A) mimics the contours of the
matrix itself. In this model cells are a continuous variable
and are represented as an average. Therefore, individual
cell processes crucial to cancer, e.g., cell-cell adhesion,
cannot be captured, thus limiting the link to experimental
observation or validation. In a more evolved version, dis-
cretizing cells (Figure 3, middle panels) allows for better
experimental validation of the model and allows for inde-
pendent behavior of individual cells, e.g., competition for
space. However, the model still lacks realism because
all cells are assumed to be identical, in spite of the well-
known coexistence of heterogeneous cell populations
within tumors. For example, in the model run as in Figure 3
(middle panels), cells are all considered as having no cell-
cell adhesion and the same proliferation rate. In the pres-
ent version, the advantages of discretizing cells become
dramatically apparent when individual phenotypes are as-
signed to each of the cells (Figure 3, lower panels). The
phenotypes are defined by mutating traits (Figure 2 and
Table 1A) based on current views of the invasive pheno-
type (Hanahan and Weinberg, 2000). In the life-cycle
flow chart, as in reality, mutations are propagated at the
time of cell division (Figure 2). The simulation with individ-
ual cell phenotypes produces a tumor fingering pattern
that is reminiscent of invading cancer (Figure 3, lower
panels). The fingering is a direct outcome of the way indi-
vidual cells interact with ECM and with each other in termsof adhesion. Cell death is also simulated as a consequence
of oxygen deprivation, resulting in a tumor core of dead
cells. It should be emphasized that individual cell traits
can be included or excluded from the life cycle, based on
their relative importance in the invasion process, as deter-
mined by experimentation.
To apply the model and simulate cancer invasion, ini-
tially we adopted a linear mutation scheme (Figure 2A).
In this scheme, cells mutate unidirectionally along a linear
pathway of four increasingly aggressive phenotypes
with predefined traits and values shown in Table 1A.
Such a scheme is reminiscent of the current models of
tumor progression, generally referred to as ‘‘vogelgrams’’
(Fearon and Vogelstein, 1990). The most aggressive phe-
notype (type IV) is characterized by shortest lag time
to proliferation, highest oxygen consumption, highest
ECM-degrading enzyme production, highest haptotactic
migration rate, and no cell-cell adhesion (Table 1A). We
simulated tumor cell proliferation in three distinct micro-
environments, characterized by initial ECM conditions re-
ferred to as homogeneous, ‘‘bumpy,’’ and ‘‘grainy’’ (Fig-
ure 4A, upper panels). Bumpy and grainy ECM represent
density variations at either the macroscale or at the same
scale as the cells, respectively. Figure 4A, middle panels,
shows the tumor morphology after simulated growth
with the linear mutation scheme for 200 generations,
approximately 4.5 months. Two distinct tumor morphol-
ogies emerge in the simulations, depending on the ECM
structure: a mass with smooth margins in the homoge-
neous matrix, as opposed to a fingering mass in the het-
erogeneous matrices. There is an obvious resemblance
between the tumor morphology in heterogenous ECM
simulations and pathological specimens of locally invasive
carcinoma. However, even though the tumor morphology
is distinct, segregation of phenotypes in the three simula-
tions is the same: dead cells in the middle, and the most
aggressive phenotype on the boundary. This is not entirely
surprising since dominance of the most aggressive phe-
notype in the linear mutation scheme is essentially prede-
termined owing to its unidirectionality. Therefore, as the
simulation proceeds in time, as soon as cells mutate into
phenotype IV, the most aggressive, they tend to dominate
the tumor mass. This is somewhat realistic: as mentioned
above, the progressive move of tumors toward increas-
ingly aggressive phenotypes is currently explained by
‘‘vogelgram’’ models of accumulation of mutations
(Fearon and Vogelstein, 1990; Michor et al., 2004). On the
other hand, it is also a common observation that tumors
are comprised of genetically heterogenous populations
of cells (Fidler, 2003), which may undergo complex com-
peting interactions during tumor evolution.
In order to eliminate the phenotype selection bias of the
linear mutation scheme, and to introduce a larger element
of phenotype diversity, we then adopted a random muta-
tion scheme (Figure 2B) in which cells are allowed to
‘‘jump’’ without restrictions to one of 100 predefined phe-
notypes. These phenotypes are generated by randomly
picking trait values with the same upper and lower boundsCell 127, 905–915, December 1, 2006 ª2006 Elsevier Inc. 907
Figure 2. Cancer Cell Life Cycle and Mutation Schemes
In the HDC model, the cancer cell life cycle enables decisions to be made about key functions, e.g., life, death, mutations, based on the interaction
between individual cell phenotypes and the local microenvironment. The first step in the cycle is examination of the local microenvironment for each
cell, e.g., oxygen concentration and proximity to other cells. Then, dependent on the individual cell phenotype, cells proliferate, die, or become qui-
escent. Mutations to another phenotype have a small probability of occurring at the time of cell division. Mutations are represented according to two
distinct strategies: (A) Linear mutation scheme. In this scheme, cell phenotypes evolve via mutation in a linear direction along four increasingly ag-
gressive, predetermined phenotypes (types I–IV), defined by traits indicated in the boxes. Once cells have reached type IV, they cannot mutate further
or revert to a less aggressive phenotype; (B) Randommutation scheme. In this scheme, cell phenotypes are randomly chosen at the time of mutation
from one of 100 predetermined phenotypes (initiated at the beginning of each simulation). At each mutation event, a cell can jump to any of the 100
phenotypes, without regard to the parent phenotype. To some degree, this scheme constitutes a simplified way of representing genetic instability.as the linear mutation scheme (Table 1A). In simulations
for the same timeframe (Figure 4A, lower panels, and
see Movies S1–S3 available with this article online), the
morphology of tumors growing in the random mutation
regime is similar to that of the linear mutation results
(Figure 4A, middle panels): smooth margins on homoge-
neous matrix and fingering on both types of heteroge-
neous matrices. In contrast to the linear mutation, how-
ever, the random mutation scheme allows determination
of which cell phenotypes are dominant at various points
in the simulation without preselection bias.
A striking result of the random mutation scheme is that
even though each of the 100 phenotypes is equally likely
to be chosen (via a mutation), only a select few actually
dominate (Figure 4B; Table 1B). In general, at the end of908 Cell 127, 905–915, December 1, 2006 ª2006 Elsevier Inc.the simulations, phenotypes selected by randommutation
have the following traits: (1) zero cell-cell adhesion; (2)
relatively low oxygen consumption; (3) high proliferation
rate; and (4) high haptotaxis coefficient (Table 1A). These
characteristics are very similar to the most aggressive
phenotype in the linear mutation scheme, with the excep-
tion of oxygen consumption (Table 1A).
These results indicate that either scheme provides a re-
alistic outcome, i.e., evolution of tumors toward increas-
ingly aggressive phenotypes. In both cases, it is important
to realize that the heterogeneous conditions (bumpy or
grainy matrix) drive selection toward a few dominant, very
aggressive clones. In contrast, the homogeneous environ-
ment with the random mutation scheme allows for co-
existence of many phenotypes, more or less aggressive.
Figure 3. Hybrid Model Development
Each row shows the simulation results from
three different stages of the HDC model devel-
opment. In these simulations, the spatiotempo-
ral evolution of cells growing and invading on a
bumpy ECMmatrix (matrix composition shown
in Figure 4A, middle panel top row) is driven by
the following models: row 1: purely continuous
partial differential equations model where cells
and other variables are considered as densities
or concentrations (colors represent cell den-
sity, as defined by the heat map on the right);
row 2: hybrid model where cells are considered
as discrete (although without a phenotype) and
the other variables as continuous concentra-
tions; row 3: hybrid model in which cells have
a phenotype and can mutate to different
phenotypes (red = dead cells; blue = the most
aggressive type IV phenotype, which comes
to dominate the population over time).This difference appears to correlate with an emergent
property of the corresponding tumor mass: under hetero-
geneous conditions, tumor morphology is invasive (finger-
ing margins), whereas under homogeneous conditions
morphology is noninvasive (smooth margins).
This correlation is intriguing, but fingeringmorphology in
the heterogeneous ECM could merely be due to superior
ability to exploit local terrain by cells with higher hapto-
taxis coefficients. On the other hand, it could be that het-
erogeneous ECM is a ‘‘harsh’’ environment that acts as
a selective force for better-adapted phenotypes. To test
this possibility, we considered a different harsh enviro-
ment, low oxygen (Figure 5A). An advantage of oxygen is
that its value can be manipulated in the course of the sim-
ulation (this may be also possible from an experimental
perspective). To avoid killing the tumor population com-
pletely we grew in silico tumors in an oxygen-rich enviro-
ment (until t = 40). We then dropped the oxygen concen-
tration to 25% of what it was and almost immediately
tumor fingers begin to emanate from the smooth circular
core. Afterwards, oxygen was treated as follows: t =
201–240 (high); t = 241–350 (low). The outcome is striking:
under harsh conditions, when oxygen is in short supply,
the morphology of the tumor is invasive (t = 200; t =
350). In mild conditions, the morphology is noninvasive
(t = 40; t = 240). Note that in these simulations the initial
ECM distribution was homogenous.
An important benefit of this simulation approach is that
at the same time as we simulate tumor growth we also
track the numbers of the different phenotypes in the
population. Figure 5B shows the resulting phenotype dis-
tribution for this simulation. The difference between thenumbers of phenotypes in the high and low oxygen micro-
environments is obvious and clearly shows the selective
ability of the harsh microenvironment. It is noteworthy that
the same three aggressive phenotypes dominate during
both periods of low oxygen conditions and have similar
aggressive traits as those selected by heterogeneous
ECM (Table 1A). In contrast, under mild conditions (high
oxygen) many clones coexist, marked by different levels
of aggressiveness, similar to the homogeneous ECM.
These results strengthen the notion thatmicroenvironment
conditions decide the invasive outcome of a tumor and
suggest a mechanism based on selection of a few domi-
nant phenotypes out of a randomly generated mixture.
Invasion appears to be an emergent property of this selec-
tion process.
Cell-cell adhesion based on homotypic interactions is
of special importance in tumor progression because
of contact inhibition and because of the association of
E-cadherin loss with metastasis and the upregulation of
other homotypic cell-cell adhesionmolecules. Our simula-
tions also point to the importance of cell-cell adhesion
since the phenotypes selected by the harsh microenviron-
ment always have zero cell-cell adhesion. We therefore
modified the HDC code in order to simulate more complex
cell-cell adhesion interactions. The overall outcome is that
even relatively minor additions to the complexity of cell-
cell adhesion phenotype traits substantially affects both
tumor evolution and morphology. For example, we intro-
duced the possibility that tumor cell clones may express
either of two distinct homotypic adhesion pairs (by anal-
ogy to the E- to N-cadherin switch that occurs in tumor
progression; Hazan et al., 2004). These simulations wereCell 127, 905–915, December 1, 2006 ª2006 Elsevier Inc. 909
Figure 4. Effect of Extracellular Matrix
Structure on Tumor Morphology and
Phenotype Selection
(A) Heterogeneous ECM induces invasive tu-
mor morphology. Simulations were run with
the current HDC model with three different ini-
tial ECM distributions (upper row), using either
the linear (middle row) or random (lower row)
mutation schemes. Density of ECM is repre-
sented by coloration, as depicted in the color
bar on the right, and is termed homogeneous,
‘‘bumpy,’’ and ‘‘grainy’’ as indicated. Cell color-
ation reflects dead cells (red) or cell-cell adhe-
sion (zero cell-cell adhesion = blue). For the lin-
ear mutation scheme, blue also represents the
most agressive phenotype (type IV, see Table
1A for representative dominant phenotypes).
For the random mutagenesis scheme, see the
entire simulations in Movies S1–S3.
(B) Heterogeneous ECM selects few, aggres-
sive tumor cell phenotypes. Phenotype distri-
butions for the randommutation scheme simu-
lations shown in Figure 4A, row 3 are depicted
here. The number of viable cells for each partic-
ular phenotype in the population over time is
represented in a three-dimensional plot for
each ECM condition. The coloration is a ‘‘heat
map’’ that represents cell number. Fewer phe-
notypes (1–3, compared with 5–7 in the homo-
geneous matrix) survive in the heterogeneous
ECM conditions, with the fewest (1–2) in the
grainy ECM. (n = 20 simulations for each condi-
tion, representative results shown).run under the randommutation regime, so that each of the
100 initial phenotypes is assigned an adhesion type (A or
B), with a corresponding adhesion value (0–3). Cells of ad-
hesion type A can only adhere to A, and B to B.
In comparison to simulations with a single adhesion
type (Figure 5), we observed the following (Figure 6): (1)
Tumors with mixed adhesion types are smaller and more
compact (Figures 6A and 6B); (2) At the first round of se-
lection with hypoxia, cells with less ‘‘aggressive’’ traits
(higher cell-cell adhesion) still coexist (Figures 6A and
6C); (3) After the second round of selection, the mixed ad-
hesion phenotypes have segregated into invasive fingers,
or lobes, of either one type or the other (Figure 6B). At this
late stage, tumor morphology is similar to the first round of
hypoxia selection in the uniform adhesion scheme (Fig-
ure 5A). These results show that the HDC model (1)
can substantially capture biological complexity, e.g., as
represented by mixed cell-cell adhesion molecules; (2) is
multiscale, i.e., molecular level events are translated into
effects at the tissue scale; (3) is suitable for validation by
current technology, whose preferred approach is based
on single gene changes, e.g., by manipulating expression
of specific cell-cell adhesion genes to generate cell popu-
lations containing mixed homotypic adhesion pairs and910 Cell 127, 905–915, December 1, 2006 ª2006 Elsevier Inc.determine their impact on tumor morphology and pheno-
type selection.
DISCUSSION
Implications of HDC Model Predictions
The HDC model makes rather specific predictions on the
mechanism of emergence of cancer invasion under selec-
tive pressure by the microenvironment. Harsh conditions
produce tumors that are morphologically invasive (finger-
ingmargins) and are dominated by one (or few) aggressive
phenotypes. In the simulations, these two conditions are
inextricably linked. In contrast, mild conditions lead to
coexistence of aggressive with less aggressive pheno-
types, no clonal dominance, and tumors with smooth,
noninvasive margins. Again, these two conditions are
strictly linked to each other. These predictions suggest
that aggressiveness of diverse cancers may be a con-
sequence of tumor growth in the context of a harsh or
mild microenvironment. This concept is consistent with
and may help explain experimental and clinical findings
showing that hypoxia or nutrient deprivation leads to inva-
sive, aggressive tumor behavior (Casanovas et al., 2005;
Erler et al., 2006; Frieboes et al., 2006; Kerbel, 1990;
Table 1. Representative Values of Traits for Tumor Cell Phenotypes Selected by the Microenvironments and
Summary of Simulation Outcomes
(A)
Traits Range
Linear
(IV)
Random
(Homogeneous)
Random
(Bumpy)
Random
(Grainy)
Random
(Low Oxygen
Switch)
Proliferation 16–8 hr 8 hr 9.4 hr 9.6 hr 9.1 hr 8.1 hr
O2 Consumption g–4g 4g 2.5g 2.1g 2.2g 2.0g
MDE Production m–4m 4m 3.5m 2.7m 2.9m 2.7m
Cell-Cell Adhesion 3–0 0 0 0 0 0
Haptotaxis c–4c 4c 3.5c 2.7c 2.9c 2.7c
(B)
Scale Microenvironment
Mild Harsh
Molecular/subcellular Aggressive traits selected Aggressive traits selected
Cellular Many phenotypes selected and coexisting 1-3 phenotypes selected and dominating
Tumor No invasive morphology Invasive morphologyPennacchietti et al., 2003). Taking it one step further, the
HDC model predicts that invasive tumor properties are
reversible under appropriate microenvironment condi-
tions (Figures 5A–5B) and suggests that differentiating
therapy aimed at cancer-microenvironment interactions
may be more useful than making the microenviron-
ment harsher (e.g., by chemotherapy or antiangiogenic
therapy).CHDC Model Variables and Parameters in Relation
to Cancer Invasion Biology
In its current version, the HDC model adopts a minimal
modeling approach, with four model variables (coupled
equations), cells, ECM, MDE, and O2. Nonetheless, it pro-
vides realistic simulations of cancer invasion. Further-
more, overly complex modeling schemes with many cou-
pled equations and parameters make it difficult to extractFigure 5. Manipulation of Oxygen
Concentrations Reveals a Global Effect
of the Microenvironment on Tumor
Morphology and Phenotype Diversity
(A) Effect of oxygen concentration on tumor
morphology. Simulations were run with the
HDC model using a homogeneous ECM distri-
bution and a switching combination of oxygen
concentrations. Oxygen is either held constant
at 1 throughout the domain (High) or set to 0.25
throughout the domain and allowed to be con-
sumed (Low). From left to right, the tumor mor-
phology in the High (from t = 0–40), Low (from
t = 40–200), High (from t = 200–240), and Low
(from t = 240–350) are represented. Cell color-
ation reflects either dead cells (brown) or the
cell-cell adhesion value (0 = blue, 1 = cyan,
2 = yellow, 3 = orange). Arrows demarcate the
growth of tumor ‘‘fingers’’ in the final low oxy-
gen environment (far right panel). (See entire
simulation in Movie S4).
(B) A mild environment (e.g., high oxygen)
allows all phenotypes to coexist where a harsh
environment (e.g., low oxygen) favors domi-
nance of fewer phenotypes in the random mutation scheme. Phenotype distribution (x axis) of the cells at various time points (y axis) is depicted
here. Coloration is a ‘‘heat map’’ and represents cell number, as indicated by the color bar on the right y axis. Note that during high oxygen conditions
(t = 0–40 and t = 200–240), all 100 phenotypes are represented whereas during low oxygen conditions (t = 40–200 and t = 240–350), there is a large
drop in the diversity of phenotypes that are expressed and the same three phenotypes become dominant again.ell 127, 905–915, December 1, 2006 ª2006 Elsevier Inc. 911
Figure 6. Effects of Homotypic Cell-Cell
Adhesion Complexity on Tumor Mor-
phology and Phenotype Diversity
(A) Effect on tumor morphology and size. Simu-
lations were run with the HDC model using a
homogeneousECMdistributionandaswitching
combinationof oxygen concentrations.Oxygen
is either held constant at 1 throughout the
domain (High) or set to 0.25 throughout the
domain and allowed to be consumed (Low).
From left to right, the tumor morphology in the
High (from t = 0–40), Low (from t = 40–200),
High (from t = 200–240), and Low (from t =
240–350) are represented. Cell coloration
reflects either dead cells (brown) or the cell-
cell adhesion value (0 = blue, 1 = cyan, 2 = yel-
low, 3 = orange). (See entire simulation in
Movie S5).
(B)Distribution of cell adhesionhomotypes. The
same simulation as in (A) but now coloration
reflects the cell-cell adhesion homotypes (A =
blue, B = green), as well as dead cells (black).
Note that there is a mix of adhesion homotypes
in most parts of the tumor (t = 40, 200, 240)
which later (t = 350) self-segregates into lobes
that contain either one or the other homotype.
(C) Effect of homotypic adhesion complexity on
phenotype selection under high-low oxygen
conditions. Phenotype distribution, repre-
sented as in Figure 5B, shows that during high
oxygen conditions (t = 0–40 and t = 200–240),
all 100 phenotypes are represented whereas during low oxygen conditions (t = 40–200 and t = 240–350), there is a large drop in the diversity of
phenotypes. However, unlike Figure 5B, the addition of homotypic adhesion complexity appears to cause some new phenotypes to emerge as
dominant at t = 240–350.key individual variables and/or parameters. It alsomakes it
much more difficult to perform experimental validation
since each variable has multiple associated parameters
to be measured. However, as we experimentally test the
model, increasing levels of complexity can be easily intro-
duced because themodel is open to incorporation of other
variables and experimental data frommultiple scales, e.g.,
the macroscale (tissue), microscale (cells), subcellular,
and molecular scales.
The HDC model has certain built-in assumptions and
dependent variables. For example, haptotaxis is a key de-
terminant of tumor cell migration and is affected by both
the initial ECM concentration and the gradients created
by MDE activity. Thus, ECM heterogeneity can dominate
tumormorphology and constitute a ‘‘harsh’’ microenviron-
ment. However, in other simulations, low oxygen concen-
trations in homogeneous ECM also provide a clonal selec-
tive force on growing tumors that results in a fingering
morphology. The specificmicroenvironmental parameters
and range of concentration values of those parameters
that act as selective forces in real life can only be deter-
mined by experimentation.
In simulations, a major qualitative change is visualized
when gross alterations of the microenvironment are intro-
duced. For instance, homogeneous versus inhomoge-
neous ECM produces a change from smooth to fingering
margins. However, more subtle alterations, e.g., from912 Cell 127, 905–915, December 1, 2006 ª2006 Elsevier Inc.bumpy to grainy ECM, produce relatively minor changes
in the fingering patterns. This prediction can only be vali-
dated by parameterizing the model, i.e., introducing into
the model actual measured values for ECM supramolecu-
lar organization, oxygen concentration in the tumor tissue,
etc. For instance, an approximation for oxygen concentra-
tion can be obtained by staining tissue sections with pimo-
nidazole, and areas of hypoxia can bemarked by carbonic
anhydrase staining. ECM organization could be deter-
mined by quantitative staining for distinct ECM molecules
in serial histological sections.
To model tumor plasticity in different microenviron-
ments, we resorted to a random mutation scheme (Fig-
ure 2B), with 100 random phenotypes. Thus, simulated
tumors generate a diversity of cell phenotypes, upon
which microenvironment forces operate selection. In this
sense, tumors modeled by the random scheme are plastic
within the range of the 100 phenotypes, though only the
adapted phenotypes survive. For example, simulations
under harsh conditions show that tumor heterogeneity is
eventually lost (though it can be regained when conditions
are mild again).
In the model (Figure 5B), alternating harsh with mild
microenvironment conditions results in reversible switch-
ing between few or many tumor cell phenotypes, respec-
tively. How could this be achieved biologically? One pos-
sibility is that tumor cells, because of intrinsic plasticity,
regenerate multiple phenotypes from a few, based per-
haps on metabolic or epigenetic adaptation to the micro-
environment. Another possibility is that a totipotent pool
of tumor stem cells radiates into many phenotypes sub-
sequently selected according to microenvironment con-
ditions while asymmetrically dividing to maintain the stem
pool independent of microenvironment. These, or other
possibilities, will have to be tested experimentally, and
the experimental outcome can be easily accommodated
in the HDC model. For instance, if existence and pheno-
typic traits of tumor stem cells are better defined experi-
mentally, then the life-cycle flow chart may have to be
modified to include a loop for asymmetrically dividing cells
with stem quality.
Experimental Validation of the HDC Model
An essential attribute of a useful mathematical model is
that its predictions should be testable experimentally,
preferably with available or accessible techniques. Key
HDC model concepts are that definable microenviron-
mental forces determine both (1) the shape of a growing
tumor (smooth versus fingering margins) and (2) the phe-
notypic composition of the tumor cell population (Tables
1A and 1B). Both of these concepts can be tested exper-
imentally, using either in vitro or in vivo methods.
For in vitro testing, a defined tumor cell line (e.g., param-
eterized with respect to rates of proliferation, apoptosis,
cell adhesion, etc.) can be expanded from single or few
cells under 2D or 3D (semi-solid media) tissue culture con-
ditions that can be varied with respect to chemical or
physical microenvironmental variables. For instance, con-
centration of specific nutrients (glucose, amino acids, or
oxygen) or the pH of the culture could be changed. These
conditions are easily controlled with current bioreactor
technology. More challenging may be to precisely control
ECM composition and gradients. However, we have
made significant strides toward producing microfluidic
devices in which gradients of ECM are easily produced
(W. Georgescu, personal communication). The advantage
of in vitro studies is that the growing tumor cells can be
observed or otherwise monitored in real time. Monocellu-
lar suspensions can also be easily prepared from these
preparations, and phenotype distribution determined,
e.g., by flow cytometry or cloning. The disadvantage is
that tumor growth in vitro is time limited, and one only tests
known variables.
In vivo testing of HDC predictions may be the most
physiologically relevant form of experimentation due to
the complex nature of tumors. The goal is to determine
the shape of the growing tumor (infiltrating verus smooth
margins) as well as clonality, as a function of microenvi-
ronmental selective forces. Certain body compartments
may be more suitable to specific microenvironment ma-
nipulations: bone, brain, kidney capsule are ‘‘bounded’’
locations into which one could manipulate and monitor
conditions of blood flow, inflammation, reactive stroma,
or hypoxia. Alternatively, test animals can be subjected
to general treatment (e.g., Avastin or other treatment to in-duce hypoxia), and the local conditions in the tumor can
be defined a posteriori, e.g., by noninvasive imaging tech-
niques, or histochemistry. This kind of retrospective anal-
ysis could also be carried out in human patients, provided
a suitable tissue collection is prepared with adequate
prognostic and historical information.
Perhaps the most challenging aspect of in vivo studies
is to define the phenotypic composition and clonality of
the growing tumor. This is particularly true of solid tumors
(the vast majority of carcinomas, of course) since disag-
gregating solid tumor specimens to produce monocellular
suspensions is cumbersome and may by itself lead to ar-
tifacts. There are several possibilities to address this prob-
lem. Phenotyping with molecular markers, e.g., for cell-
cell adhesion, proliferation, and motility, could be done
by conventional immunohistochemical methods on tissue
sections, and possibly 3D reconstruction of a tumor spec-
imen, in order to connect phenotypes and their relative
dominance with tumor morphology. Clonality can be ad-
dressed using mixtures of pre-tagged tumor cells that
can be identified in the tumor by histochemical staining
or molecular genetic methods.
It is important to note that portions of these experiments
have been performed by other investigators but not been
organized in a cohesive framework. For instance, recent
experiments have addressed the role of hypoxia in pro-
moting aggressive behavior and invasive morphology
(Casanovas et al., 2005; Erler et al., 2006; Pennacchietti
et al., 2003) but did not examine the clonal or phenotypic
composition of resulting tumors. Kerbel and colleagues
performed a number of studies examining clonal evolution
of primary tumors (Korczak et al., 1988; Rak and Kerbel,
1993) but did not examine invasive behavior at the tissue
scale or specific phenotypes selected for. Nonetheless,
these experiments underscore the feasibility of HDC
model validation.
HDC Model Concepts in Context of Tumor
Progression Theories
The concept of tumor microenvironment as a factor in
cancer progression has important precedents. Thus, the
microenvironment has been proposed to play a part in
the promotion phase of classic two-stage tumorigenesis
systems (Rubin, 2003) and is perhaps relevant in Paget’s
seed-soil hypothesis to explain site preference of meta-
static growth (Fidler, 2003). Recently, several groups
demonstrated the involvement of microenvironmental fac-
tors in tumor progression and proposed that the microen-
vironment may promote (Bhowmick et al., 2004; Kuper-
wasser et al., 2004) or suppress (Bissell et al., 2002;
Matrisian et al., 2001) cancer progression through signal-
ing mechanisms. In contrast, the HDC model indicates
that the microenvironment may function as a Darwinian
selective agent that favors the emergence of aggressive,
invasive clones: simulations under harsh conditions select
inevitably for the most aggressive clones, whereas under
mild conditions clones with different levels of aggressive-
ness can coexist. This is reminiscent of evolutionaryCell 127, 905–915, December 1, 2006 ª2006 Elsevier Inc. 913
selection in theories of quasi-species (Eigen, 1993) or ge-
nomic instability (Cahill et al., 1999; Michor et al., 2005).
Nowell proposed in 1976 that the clonal evolution of
cancer suggests positive selection of variant sublines,
particularly with regard to mutations that confer advan-
tages with respect to competition for space and nutrients
or to chemotherapy resistance (Nowell, 1976). Consistent
with Nowell’s theory, in the HDC model, certain genetic
traits (e.g., unrestrained proliferation, motility) are a neces-
sary condition for cancer progression. Importantly, in addi-
tion, the HDC model makes the novel prediction that both
tumormorphology and the dominance of the invasive phe-
notypes are a direct outcome of selection by the micro-
environment (Figures 4–6). More recently, Weinberg and
Hanahan also recognized that cancer progression has the
properties of classic Darwinian evolution (Hanahan and
Weinberg, 2000), and natural selection in the progression
of neoplasia has been advocated in several human sys-
tems (Maley and Reid, 2005). The HDC model provides
a powerful tool to test these propositions and provide
mechanistic insights through quantitative simulations
that determine how combinations of microenvironmental
and cellular parameters cause invasive tumor growth.
In retrospect, the HDC model appears to directly sup-
port the ‘‘clonal dominance’’ theory of cancer metastasis,
articulated by Kerbel (Kerbel, 1990) and others in the
1980s and early 1990s. Briefly, Kerbel argued that a major
trait of invasive cells is their independence from growth
factors, reproducibly arising under harsh microenviron-
ment conditions. Furthermore, he suggested that metas-
tasis is the consequence of such clones taking over and
dominating the primary tumor. This view of clonal domi-
nance by the invasive/metastatic cancer cell agrees well
with predictions of theHDCmodel. However, it is in appar-
ent contrast to the prevailing ‘‘dogma’’ that metastatic
cells are rare variants randomly occurring in a primary
tumor overwhelmingly comprised of metastasis-incompe-
tent cells. These latter views are perhaps best represented
by the Fidlermetaphor of themetastatic cell as a decathlon
winner (Fidler, 2003). In contrast, the HDC model clearly
predicts that conditions of harsh microenvironment lead
to primary tumors almost entirely comprised of the most
aggressive clonal populations. Furthermore, the HDC
model predicts that these aggressive populations realize
their invasive potential only if harsh microenvironment
conditions persist or arise.
Experimental support for the clonal dominance theory
comes from studies in which retrovirus-tagged tumor cells
weremixed and allowed to evolve in in vitro and in vivo en-
vironments (Korczak et al., 1988). Remarkably, if in vivo or
in vitro conditions were restrictive, metastatic cells always
dominated over nonmetastatic tumor cell populations,
despite equal growth rates both in vitro and in vivo (Rak
and Kerbel, 1993). Dominance of the metastatic cells
within the primary tumor correlated with the development
of metastases. The role of a harsh microenvironment in
promoting clonal dominance was further tested by Yu
et al. in a study that showed that hypoxia promotes dom-914 Cell 127, 905–915, December 1, 2006 ª2006 Elsevier Inc.inance of p53 null cells in mixed tumors of p53 null and
wild-type cells (Yu et al., 2002). These results are consis-
tent with recent clinical studies showing that metastases
have the same genotype as primary tumors (Ramaswamy
et al., 2003).
The debate among alternative metastasis theories
(clonal dominance, dynamic heterogeneity, etc.), fueled
by extensive and creative experimental work (Kerbel,
1990; Weiss, 1990), is still unresolved due to the difficulty
of reaching clear-cut experimental conclusions from
experimental work. This outcome underscores how re-
ductionist approaches, classically used in experimental
biology, are inadequate when used alone to capture the
complexity of tumor progression and the rise of metasta-
sis. In contrast, we propose that a mathematical simula-
tion approach, such as described here, provides a plat-
form for considering many variables at once and can
continue that debate interactively with experimentation.
Future Directions
Above, we provided only a few of many possible validation
scenarios, but essentially most of current cancer biology
can be appropriately represented and used for validation
of the HDC model. Eventually, mathematical representa-
tion of molecular networks will be introduced. At the
moment, this is impractical for at least three reasons: (1)
There is no good agreement as to how even the best
known molecular circuitry (e.g., cell cycle) should be rep-
resented; (2) Computational power is still limiting to run
these sorts of models feasibly in reasonable time; and
(3) The effect of a single molecular change on any or all
of the model variables is difficult to predict and needs to
be defined experimentally (this is in fact a subject of cur-
rent experimentation in our Center).
A long-term goal of the modeling effort is to be able to
predict invasive behavior of individual tumors based on
actual measurements of cellular and microenvironmental
parameters. If successful, such a predictive tool could
be useful in drug discovery, or in the management of can-
cer patients. For example, high-resolution imaging tech-
niques that quantitate critical properties of cancer cells
and of the tumor microenvironment, in combination with
mathematical modeling, could be used as an adjunctive
aid to customize therapy in individual patients.
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